definiens: means any day other than a Saturday, Sunday or statutory holiday in the Province of Ontarioand June 24 ; ( c ) and means the blood management organization in Canada, except for theprovince of Quebec ; ( d ) means the statute of Canada cited as R.S.C. 1985, c. F-27 and regulationsthereto, as amended from time to time ; ( e ) means those sites identified in Schedule ; 2 of 52 ( f ) means all products listed in Schedule and all additions, substitutions and deletionsto the Schedule from time to time occurring during the Term of this Agreement and a Commercial Productmeans any one of them ; ( g ) means individuals to be infused with Commercial Products or Fractionation Products or the legalguardians / trustees of these individuals ; ( h ) means the annual average indexes obtained by averaging the indexes for the twelve ( 12)months of the calendar year, as published by Statistics Canada at the end of the previous calendar year ; ( i ) means April 1, 2005 ; ( j ) means the Food and Drug Administration of the United States of America, or any successor thereto ; ( k ) means the Plasma Intermediates and products resulting from the process wherebyTalecris fractionates Plasma ; ( l ) means the fractionation a of Plasma into Fractionation Products ; ( m ) means Her Majesty the Queen in right of Canada as represented by the federal Minister ofHealth and is the Regulator of Products in Canada ; ( n ) Intentionally Deleted ; ( o ) means a change to any Product or Fractionation Service which enhances the safety, efficacy, identity, potency or purity of the Product ; ( p ) means Her Majesty the Queen in right of Canada as represented by the federal Minister ofIndustry ; ( q ) means a product licensed by Health Canada for sale or distribution in Canada ; ( r ) means the research fund supported by [COMPANY] Canada and administered by [COMPANY] Canada, CBS and HQ whereby research grants are provided, based on merit for research in the area of biologicals andblood products ; ( s ) means Recovered Plasma and Source Plasma collected in Canada excluding cryosupernatantplasma ; ( t ) means any by - products produced during the fractionation of the Plasma by Talecrisand returned to CBS or as directed by CBS from time to time ; ( u ) means collectively Fractionation Products and Commercial Products ; ( v ) or includes the product monograph, all labeling, package inserts andpackaging for the Products as approved by Health Canada and, for Commercial Products as set out inSchedule as amended from time to time ; 3 of 52 ( w ) means any action ordered by Talecris or [COMPANY] Canada to remove a Product from further distributionor use, or correction, of a Product that violates legislation administered by Health Canada, the FDA, or anyother regulatory body with authority ; ( x ) means the liquid portion of human blood that remains after separation of the cellularelements from blood ; ( y ) means products required by HQ pursuant to Sections 6.12, 7.2 and 7.3and a Replacement Fractionation Product means any one of them ; ( z ) means products required by HQ pursuant to Sections 3.8, 3.9, 11.4 and 15.1 and aReplacement Product means any one of them ; ( aa ) means the services expressly set out herein to be provided by Talecris, including the fractionationof Plasma into Fractionation Products ; ( bb ) means that the total inventory of any Product, issuable and not subject to a quarantine, Recall orWithdrawal, of Fractionation Products and/or Commercial Products [ * * * ] ; ( cc ) means Plasma collected by apheresis ; ( dd ) and means Health Canada ’s program to authorize distribution of unlicensedproduct in Canada ; ( ee ) means the target inventory for Fractionation Products and Commercial Products as set out inSchedule and any changes thereto as agreed in writing by the Parties ; ( ff ) means that period of time commencing on the Effective Date and ending at the earlier of : ( i ) March 31, 2007 ; and ( ii ) termination of this Agreement as provided for herein